PL322722A1 - Novel heterocyclic compounds - Google Patents
Novel heterocyclic compoundsInfo
- Publication number
- PL322722A1 PL322722A1 PL96322722A PL32272296A PL322722A1 PL 322722 A1 PL322722 A1 PL 322722A1 PL 96322722 A PL96322722 A PL 96322722A PL 32272296 A PL32272296 A PL 32272296A PL 322722 A1 PL322722 A1 PL 322722A1
- Authority
- PL
- Poland
- Prior art keywords
- heterocyclic compounds
- novel heterocyclic
- novel
- compounds
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK40595 | 1995-04-07 | ||
| DK100595 | 1995-09-11 | ||
| PCT/DK1996/000139 WO1996031498A1 (en) | 1995-04-07 | 1996-04-01 | Novel heterocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL322722A1 true PL322722A1 (en) | 1998-02-16 |
| PL187171B1 PL187171B1 (en) | 2004-05-31 |
Family
ID=26063928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL96322722A PL187171B1 (en) | 1995-04-07 | 1996-04-01 | Novel heterocyclic compounds |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5874428A (en) |
| EP (1) | EP0820451B1 (en) |
| JP (1) | JPH11503127A (en) |
| KR (1) | KR100466915B1 (en) |
| CN (1) | CN1152030C (en) |
| AR (1) | AR007759A1 (en) |
| AT (1) | ATE231144T1 (en) |
| AU (1) | AU708010B2 (en) |
| CA (1) | CA2217197A1 (en) |
| CZ (1) | CZ291294B6 (en) |
| DE (1) | DE69625806T2 (en) |
| DK (1) | DK0820451T3 (en) |
| ES (1) | ES2191090T3 (en) |
| HU (1) | HUP9800719A3 (en) |
| IL (1) | IL117810A (en) |
| MX (1) | MX9707531A (en) |
| NO (1) | NO974605L (en) |
| PL (1) | PL187171B1 (en) |
| RU (1) | RU2244713C2 (en) |
| TW (1) | TW419463B (en) |
| UA (1) | UA54385C2 (en) |
| WO (1) | WO1996031498A1 (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6239148B1 (en) * | 1994-01-04 | 2001-05-29 | Novo Nordisk A/S | N-substituted azaheterocyclic carboxylic acids and esters thereof |
| WO1998002151A2 (en) | 1996-07-12 | 1998-01-22 | Leukosite, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6323206B1 (en) | 1996-07-12 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| ZA978792B (en) * | 1996-10-04 | 1998-04-06 | Novo Nordisk As | N-substituted azaheterocyclic compounds. |
| DE69720021T2 (en) * | 1996-10-04 | 2004-02-05 | Novo Nordisk A/S | 1,4-DISUBSTITUTED PIPERAZINE |
| JP2002508353A (en) * | 1997-12-17 | 2002-03-19 | ノボ ノルディスク アクティーゼルスカブ | New heterocyclic compounds |
| US6048856A (en) * | 1997-12-17 | 2000-04-11 | Novo Nordisk A/S | Heterocyclic compounds |
| US6613905B1 (en) * | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6509346B2 (en) * | 1998-01-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| CA2319077A1 (en) * | 1998-01-21 | 1999-07-29 | Yoshisuke Nakasato | Chemokine receptor antagonists and methods of use therefor |
| US6433165B1 (en) | 1998-01-21 | 2002-08-13 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| AU2825999A (en) * | 1998-03-17 | 1999-10-11 | Novo Nordisk A/S | Novel heterocyclic compounds |
| US6214816B1 (en) | 1998-03-17 | 2001-04-10 | Novo Nordisk A/S | Heterocyclic compounds |
| US6503926B2 (en) | 1998-09-04 | 2003-01-07 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US7271176B2 (en) * | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
| US6288083B1 (en) | 1998-09-04 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| US7541365B2 (en) * | 2001-11-21 | 2009-06-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| TWI291467B (en) * | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
| EA200701782A3 (en) | 2003-04-24 | 2008-04-28 | Инсайт Корпорейшн | DERIVATIVES OF AZASPYROALKANES AS METHOD PROTEASIS INHIBITORS |
| US20070066570A1 (en) * | 2003-06-16 | 2007-03-22 | Michael Solomon | Methods for treating sleep disorders |
| PL2041088T3 (en) | 2006-06-28 | 2014-07-31 | Amgen Inc | Glycine transporter-1 inhibitors |
| JP7471818B2 (en) * | 2016-08-18 | 2024-04-22 | ヴィダック ファーマ リミテッド | Piperazine derivatives, pharmaceutical compositions, and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL99690C (en) * | 1956-11-15 | |||
| FR1296519A (en) * | 1959-05-05 | 1962-06-22 | Abbott Lab | Process for the preparation of phenothiazines substituted on nitrogen, preferably with a substituted pyrrolidinoalkyl group |
| DE1159954B (en) * | 1961-11-25 | 1963-12-27 | Boehringer & Soehne Gmbh | Process for the production of new 10- (alkoxypiperidinopropyl) -phenthiazines and their salts |
| CH454871A (en) * | 1964-01-24 | 1968-04-30 | Geigy Ag J R | Process for the production of new salts of emboxylic acid |
| GB1517385A (en) * | 1975-08-29 | 1978-07-12 | Eisai Co Ltd | Phenothiazine derivatives |
| MY113463A (en) * | 1994-01-04 | 2002-03-30 | Novo Nordisk As | Novel heterocyclic compounds |
-
1996
- 1996-01-04 UA UA97104938A patent/UA54385C2/en unknown
- 1996-03-28 US US08/623,289 patent/US5874428A/en not_active Expired - Fee Related
- 1996-04-01 KR KR1019970707083A patent/KR100466915B1/en not_active IP Right Cessation
- 1996-04-01 RU RU97118474/04A patent/RU2244713C2/en not_active IP Right Cessation
- 1996-04-01 CN CNB961937793A patent/CN1152030C/en not_active Expired - Fee Related
- 1996-04-01 HU HU9800719A patent/HUP9800719A3/en unknown
- 1996-04-01 WO PCT/DK1996/000139 patent/WO1996031498A1/en active IP Right Grant
- 1996-04-01 MX MX9707531A patent/MX9707531A/en unknown
- 1996-04-01 JP JP8529868A patent/JPH11503127A/en not_active Ceased
- 1996-04-01 PL PL96322722A patent/PL187171B1/en not_active IP Right Cessation
- 1996-04-01 AU AU51003/96A patent/AU708010B2/en not_active Ceased
- 1996-04-01 AT AT96907327T patent/ATE231144T1/en not_active IP Right Cessation
- 1996-04-01 EP EP96907327A patent/EP0820451B1/en not_active Expired - Lifetime
- 1996-04-01 DE DE69625806T patent/DE69625806T2/en not_active Expired - Fee Related
- 1996-04-01 DK DK96907327T patent/DK0820451T3/en active
- 1996-04-01 ES ES96907327T patent/ES2191090T3/en not_active Expired - Lifetime
- 1996-04-01 CZ CZ19973164A patent/CZ291294B6/en not_active IP Right Cessation
- 1996-04-01 CA CA002217197A patent/CA2217197A1/en not_active Abandoned
- 1996-04-03 AR ARP960102088A patent/AR007759A1/en unknown
- 1996-04-03 IL IL11781096A patent/IL117810A/en not_active IP Right Cessation
- 1996-05-14 TW TW085104810A patent/TW419463B/en not_active IP Right Cessation
-
1997
- 1997-10-06 NO NO974605A patent/NO974605L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1152030C (en) | 2004-06-02 |
| IL117810A0 (en) | 1996-08-04 |
| KR100466915B1 (en) | 2005-04-14 |
| TW419463B (en) | 2001-01-21 |
| JPH11503127A (en) | 1999-03-23 |
| DE69625806T2 (en) | 2004-01-22 |
| CN1183781A (en) | 1998-06-03 |
| IL117810A (en) | 2001-09-13 |
| CA2217197A1 (en) | 1996-10-10 |
| AU5100396A (en) | 1996-10-23 |
| CZ316497A3 (en) | 1998-03-18 |
| HUP9800719A3 (en) | 1999-09-28 |
| NO974605L (en) | 1997-12-04 |
| MX9707531A (en) | 1997-11-29 |
| DE69625806D1 (en) | 2003-02-20 |
| PL187171B1 (en) | 2004-05-31 |
| EP0820451A1 (en) | 1998-01-28 |
| CZ291294B6 (en) | 2003-01-15 |
| WO1996031498A1 (en) | 1996-10-10 |
| UA54385C2 (en) | 2003-03-17 |
| RU2244713C2 (en) | 2005-01-20 |
| AU708010B2 (en) | 1999-07-29 |
| HUP9800719A2 (en) | 1999-06-28 |
| NO974605D0 (en) | 1997-10-06 |
| ATE231144T1 (en) | 2003-02-15 |
| ES2191090T3 (en) | 2003-09-01 |
| DK0820451T3 (en) | 2003-05-12 |
| US5874428A (en) | 1999-02-23 |
| AR007759A1 (en) | 1999-11-24 |
| KR19980703684A (en) | 1998-12-05 |
| EP0820451B1 (en) | 2003-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24195A (en) | Heterocyclic compounds | |
| ZA9610020B (en) | Heterocyclic compounds | |
| GB9512697D0 (en) | Heterocyclic compounds | |
| GB9518552D0 (en) | New heterocyclic compounds | |
| PL322722A1 (en) | Novel heterocyclic compounds | |
| GB9504361D0 (en) | Heterocyclic compounds | |
| GB9408872D0 (en) | Heterocyclic compounds | |
| AU5271096A (en) | Novel heterocyclic compounds | |
| PL325637A1 (en) | Novel heterocyclic compounds | |
| AU5270896A (en) | Novel heterocyclic compounds | |
| GB9401921D0 (en) | Heterocyclic compounds | |
| GB9401994D0 (en) | Heterocyclic compounds | |
| ZA962734B (en) | Heterocyclic compounds | |
| AU5271696A (en) | Novel heterocyclic compounds | |
| AU5271896A (en) | Novel heterocyclic compounds | |
| AU5272096A (en) | Novel heterocyclic compounds | |
| ZA962738B (en) | Heterocyclic compounds | |
| ZA962737B (en) | Heterocyclic compounds | |
| GB9504362D0 (en) | Heterocyclic compounds | |
| ZA964615B (en) | Heterocyclic compounds | |
| GB9519893D0 (en) | Heterocyclic compounds | |
| GB9500521D0 (en) | Heterocyclic compounds | |
| ZA962736B (en) | Heterocyclic compounds | |
| GB9504383D0 (en) | Heterocyclic compounds | |
| ZA962732B (en) | Heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20060401 |